S100B and early-onset autosomal dominant Alzheimer disease: Studies have shown that enhanced S-100β upregulated the cyclooxygenase-2 expression by way of RAGE in microglia [47], and in those with Alzheimer disease cyclooxygenase-2 inhibitor impeded neuro-inflammation and induced amelioration of cognitive function [48].